Medical Devices

A global pioneer and a top US expert join forces to bring a minimally invasive pain therapy to millions of Americans through a revolutionary outpatient model.

A Long Island father saw a teen's plea for a kidney on the news. His decision to donate not only saved a life but forged an unbreakable bond between strangers.

South Korea's Miracell has secured FDA clearance for its SMART M-CELL system, challenging established players in the booming U.S. regenerative medicine market.

A new collaboration between Emporia Research and Definitive Healthcare promises unprecedented accuracy in recruiting healthcare decision-makers for vital research.

A new study shows the feasibility of a single device for glucose monitoring and insulin delivery, aiming to simplify life for millions with diabetes.

Jetstream Venture Fund's deals with Surf Therapeutics and Hill Research signal a new era of accessible venture capital backing transformative technologies.

My Derma Dream's MyoGlow promises a surgery-free arm lift. We investigate the science, the marketing, and the guarantee fine print consumers must see.

A new company is selling franchises to doctors and pharmacists, promising to cut out insurers and restore local care. But can this bold model survive the system?

As AI and voice search change how patients find dentists, Gargle is integrating new AEO and GEO tools to keep practices visible. Here's what it means.

Backed by FDA approval and strong clinical data, EBR Systems' leadless WiSE pacer is set to transform cardiac therapy for previously untreatable patients.

A 26-spot jump in U.S. News rankings reveals how Auburn's targeted investments in new programs and facilities are paying off for students and the state.

Highridge Medical's new deal for the Waypoint GPS brings a radiation-free, cost-effective navigation tool to spine surgery, challenging complex robotics.

With late-stage trials for two common eye conditions affecting millions, Cloudbreak Pharma is advancing novel drops where no approved drugs exist.

Positive Phase 1b data for two novel drugs suggests a long-acting, once-monthly oral therapy for recurrent genital herpes may be on the horizon.

Behavior Labs launches a new platform to close the life sciences' 'ground truth gap,' replacing slow quarterly reviews with continuous, daily intelligence.

Vafa Jamali, known for a $1.75B exit, joins CIRCA's board, signaling a major growth push beyond monitoring into advanced cardiac access technologies.

With a personal family connection to type 1 diabetes and a £100M war chest, Anastasia Bukhman joins the T1D Fund's board to speed up research.

New Medicare billing codes for the biosimilar Tyenne are now in effect, simplifying reimbursement and aiming to improve access for severe COVID-19 patients.

A Sarasota innovator challenges orthopedic giants with a resorbable device that works with the body, promising faster, better patient recovery.

With its European trial launch, Kainova's DT-7012 aims to disarm cancer's bodyguards, offering new hope for patients with advanced solid tumors.